diaminopimelic acid has been researched along with Diabetes Mellitus, Type 2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, F; Ding, Q; Guo, H; Guo, Z; Huang, Y; Weng, S; Zhang, H; Zhang, X; Zheng, Z | 1 |
| Agra, N; Benito, G; Boscá, L; Delgado, C; Fernández-Velasco, M; González-Peramato, P; Gonzalez-Ramos, S; Martín-Sanz, P; Pacheco, I; Prieto, P; Terrón, V; Val-Blasco, A; Vallejo-Cremades, MT | 1 |
2 other study(ies) available for diaminopimelic acid and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Multi-omics Analysis Reveals the Crucial Mediators of DJB in the Treatment of Type 2 Diabetes.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Diaminopimelic Acid; Duodenum; Glucose; Jejunum; Multiomics; Obesity, Morbid; Rats; RNA, Ribosomal, 16S | 2023 |
NOD1 activation in cardiac fibroblasts induces myocardial fibrosis in a murine model of type 2 diabetes.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diaminopimelic Acid; Endomyocardial Fibrosis; Gene Expression Regulation; Humans; Insulin; Insulin Resistance; Mice; Mice, Transgenic; Myocardium; NF-kappa B; NIH 3T3 Cells; Nitriles; Nod1 Signaling Adaptor Protein; Signal Transduction; Sulfones; Transforming Growth Factor beta | 2017 |